Condition: Paroxysmal Atrial Fibrillation · Persistent Atrial Fibrillation · Sponsor: Vivek Reddy
This is a Prospective, controlled, single-blind, randomized (2:1, Intervention:Control) clinical trial. The purpose of the study is to determine the role of adjunctive renal sympathetic denervation in the prevention of Atrial Fibrillation (AF) recurrence in patients with hypertension scheduled for a redo AF ablation procedure for paroxysmal or persistent AF. Patients will be randomized to either i) AF ablation (Control) or ii) AF ablation + renal sympathetic denervation (Intervention).
This description comes directly from the study's public registry record.
Jeff Lam, MS · (212) 824-8929 · jeff.lam@mountsinai.org
Betsy Ellsworth, MSN ANP · (212) 824-8902 · betsy.ellsworth@mountsinai.org
Always discuss trial participation with your own doctor first.
| Arrhythmia Research Group | Jonesboro, Arkansas, United States | Recruiting |
| UCSF | San Francisco, California, United States | Recruiting |
| Los Robles Medical Center | Thousand Oaks, California, United States | Recruiting |
| Henry Ford Health System | Detroit, Michigan, United States | Recruiting |
| Mount Sinai Hospital | New York, New York, United States | Recruiting |
| Trident Medical Center | Charleston, South Carolina, United States | Recruiting |
| Christus | Tyler, Texas, United States | Recruiting |
| Virginia Commonwealth University | Richmond, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05988411